Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period by Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Sabada Dube, Cátia Ferreira, Idit Livnat, Carla Talarico, Sylvia Taylor, Sudhir Venkatesan, Adva Yarden, Ran D. Balicer, Doron Netzer, Alon Peretz

Get full text